# IMMPHENTIV
> **NDA203826** · New Drug Application · Sponsor: HIKMA · Approved 2012-12-20
## Drug
- **FDA Application Number:** NDA203826
- **Application type:** New Drug Application
- **Brand name:** IMMPHENTIV
- **Generic name:** PHENYLEPHRINE HYDROCHLORIDE
- **Active ingredients:** PHENYLEPHRINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** HIKMA
- **Manufacturer:** Hikma Pharmaceuticals USA Inc.
- **First approval:** 2012-12-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203826)
---
*MORVS · CC0 1.0*